The drugmaker Novo Nordisk can meet current and future demand in the U.S., the Food and Drug Administration said ... will ...

Hims & Hers Health shares swooned after the Food & Drug Administration said the active ingredient in Ozempic and Wegovy is no longer in short supply. The company makes compounded versions of ...

The FDA has now resolved the shortages of Novo Nordisk and Eli Lilly’s blockbuster weight-loss drugs, which could spell the ...

President Trump's government overhaul in annual reports, highlighting risks from tariffs to healthcare reforms.